Promotion of GDF11 on osteoblast differentiation of ADSCs derived from diabetic mice by activating PI3K/Akt signaling pathway
GONG Min1, ZHU Biao2, LI Xin3, MEI Mei1, DANG Ruijie2, CHEN Ye1
1. Department of Stomatology, Yuquan Hospital of Tsinghua University, Beijing 100040, China; 2. PLA Medical School, Beijing 100853, China; 3. Department of Stomatology, Beijing Shijingshan Hospital, Beijing 100043, China
Abstract:Objective To investigate the effects of growth differentiation factor 11 (GDF11) on osteoblast differentiation of adipose derived stem cells (ADSCs) from diabetic mice and related signaling mechanism. Methods ADSCs from diabetic mice were isolated and cultured. The effect of GDF11 on the proliferation of ADSCs was detected by flow cytometry. After cultured in osteogenic differentiation medium, ALP activity was detected, qPCR was used to evaluate the expression of osteoblast genes, and phosphorylation levels of PI3K and Akt were detected by western blot. Results Cell proliferation was less affected by GDF11 intervation, promoted ALP activity in a concentration-dependent but saturated manner, significantly upregulated mRNA expression of Runx2 (2.41±0.19) vs. (1.00±0.11)], Osx [(1.41±0.21) vs. (1.00±0.10)] and ALP [(1.42±0.20) vs. (1.00±0.09)] (P<0.05), and significantly increased phosphorylation levels of PI3K [(2.84±0.19) vs. (1.00±0.11)] and Akt [(4.58±0.20) vs. (1.00±0.19)] (P<0.05). Moreover, the effects of GDF11 on promoting osteoblast differentiation of ADSCs from diabetic mice was partially weakened by the PI3K inhibitor LY294002. Conclusions GDF11 promotes osteoblast differentiation of ADSCs from diabetic mice, and its mechanism may be related with the activation of PI3K/Akt signaling pathway.
龚闽, 朱彪, 李欣, 梅美, 党瑞杰, 陈晔. 生长分化因子11激活PI3K/Akt信号途径促进糖尿病小鼠ADSCs体外矿化的研究[J]. 武警医学, 2024, 35(1): 25-29.
GONG Min, ZHU Biao, LI Xin, MEI Mei, DANG Ruijie, CHEN Ye. Promotion of GDF11 on osteoblast differentiation of ADSCs derived from diabetic mice by activating PI3K/Akt signaling pathway. Med. J. Chin. Peop. Armed Poli. Forc., 2024, 35(1): 25-29.
Danaei G, Finucane M M, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants[J]. Lancet, 2011,378(9785):31-40.
Gao J, Wang H, Shen J, et al. Mutual regulation between GDF11 and TET2 prevents senescence of mesenchymal stem cells[J]. J Cell Physiol, 2023.
[5]
Mei W, Xiang G, Li Y, et al. GDF11 protects against endothelial injury and reduces atherosclerotic lesion formation in apolipoprotein E-null mice[J]. Mol Ther, 2016,24(11):1926-1938.
[6]
Li H, Li Y, Xiang L, et al. GDF11 attenuates development of type 2 Diabetes via improvement of islet β-cell function and survival[J]. Diabetes, 2017,66(7):1914-1927.
[7]
Zhang J, Li Y, Li H, et al. GDF11 improves angiogenic function of EPCs in diabetic limb ischemia[J]. Diabetes, 2018,67(10):2084-2095.
Loffredo F S, Steinhauser M L, Jay S M, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy[J]. Cell, 2013,153(4):828-839.
[12]
Katsimpardi L, Litterman N K, Schein P A, et al. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors[J]. Science, 2014,344(6184):630-634.
[13]
Sinha M, Jang Y C, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle[J]. Science, 2014,344(6184):649-652.
[14]
Zhang C, Lin Y, Liu Q, et al. Growth differentiation factor 11 promotes differentiation of MSCs into endothelial-like cells for angiogenesis[J]. J Cell Mol Med, 2020,24(15):8703-8717.
[15]
Zhao Y, Zhu J, Zhang N, et al. GDF11 enhances therapeutic efficacy of mesenchymal stem cells for myocardial infarction via YME1L-mediated OPA1 processing[J]. Stem Cells Transl Med, 2020,9(10):1257-1271.
[16]
Zhang Y, Shao J, Wang Z, et al. Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma[J]. Gene, 2015,557(2):209-214.
[17]
Shen G S, Zhou H B, Zhang H, et al. The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis[J]. Biochim Biophys Acta Mol Basis Dis, 2018,1864(12):3644-3654.
[18]
Lu Q, Tu M L, Li C J, et al. GDF11 inhibits bone formation by activating Smad2/3 in bone marrow mesenchymal stem cells[J]. Calcif Tissue Int, 2016,99(5):500-509.
[19]
Liu W, Zhou L, Zhou C, et al. GDF11 decreases bone mass by stimulating osteoclastogenesis and inhibiting osteoblast differentiation[J]. Nat Commun, 2016,7:12794.
[20]
Wang S, Wang L, Shi S, et al. Inhibition of GDF11 could promote bone healing in the tooth extraction socket and facilitate mesenchymal stem cell osteogenic differentiation in T2DM pigs[J]. J Periodontol, 2020,91(12):1645-1652.
Meng J, Ma X, Wang N, et al. Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through β-catenin[J]. Stem Cell Reports, 2016,6(4):579-591.